Related Experiment Video
Updated: Jul 4, 2025

In utero Electroporation followed by Primary Neuronal Culture for Studying Gene Function in Subset of Cortical Neurons
Published on: October 8, 2010
Dual effects of ARX poly-alanine mutations in human cortical and interneuron development
Insights
Mutations in the Aristaless-related homeobox (ARX) gene cause infantile spasms. Human brain organoid models reveal ARX mutations disrupt neuronal development and migration, offering new therapeutic targets for this devastating childhood epilepsy.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Infantile spasms are a severe childhood epilepsy linked to intellectual disability.
- Mutations in the Aristaless-related homeobox (ARX) gene are found in approximately 5% of affected males.
- Existing animal models do not fully replicate human infantile spasms, highlighting the need for human-specific models.
Purpose of the Study:
- To investigate the impact of Aristaless-related homeobox (ARX) gene mutations, specifically the PAE mutation, on human brain development using organoid models.
- To understand the cellular and molecular mechanisms underlying ARX-related infantile spasms and developmental epilepsies.
Main Methods:
- Utilized human cortical organoids (COs) and ganglionic eminence organoids (GEOs) to model cortical and interneuron development.
- Analyzed the effects of ARX PAE mutations on gene expression, cell migration, and cell proliferation in organoid models.
- Investigated potential therapeutic interventions by inhibiting CXCR4 to rescue observed migration defects.
Main Results:
- ARX PAE mutations led to decreased ARX expression and enhanced interneuron migration in GEOs, a phenotype reversible by CXCR4 inhibition.
- Observed an initial increase in radial glia and intermediate progenitor cells, followed by a loss of cortical neurons in organoid models.
- Found ARX upregulation and altered CDKN1C expression in patient-derived COs, with ARX PAE assembloids exhibiting early hyperactivity.
Conclusions:
- Human brain organoid models effectively recapitulate key aspects of ARX-related infantile spasms and developmental epilepsies.
- ARX PAE mutations disrupt crucial developmental processes, including interneuron migration and neuronal cell populations.
- Targeting ARX PAE pathways in human organoids provides a promising avenue for developing novel therapeutic strategies for infantile spasms.
Abstract:
Infantile spasms, with an incidence of 1.6 to 4.5 per 10,000 live births, are a relentless and devastating childhood epilepsy marked by severe seizures but also leads to lifelong intellectual disability. Alarmingly, up to 5% of males with this condition carry a mutation in the Aristaless-related homeobox ( ARX ) gene. Our current lack of human-specific models for developmental epilepsy, coupled with discrepancies between animal studies and human data, underscores the gap in knowledge and urgent need for innovative human models, organoids being one of the best available. Here, we used human neural organoid models, cortical organoids (CO) and ganglionic eminences organoids (GEO) which mimic cortical and interneuron development respectively, to study the consequences of PAE mutations, one of the most prevalent mutation in ARX . ARX PAE produces a decrease expression of ARX in GEOs, and an enhancement in interneuron migration. That accelerated migration is cell autonomously driven, and it can be rescued by inhibiting CXCR4. We also found that PAE mutations result in an early increase in radial glia cells and intermediate progenitor cells, followed by a subsequent loss of cortical neurons at later timepoints. Moreover, ARX expression is upregulated in COs derived from patients at 30 DIV and is associated with alterations in the expression of CDKN1C . Furthermore, ARX PAE assembloids had hyperactivity which were evident at early stages of development. With effective treatments for infantile spasms and developmental epilepsies still elusive, delving into the role of ARX PAE mutations in human brain organoids represents a pivotal step toward uncovering groundbreaking therapeutic strategies.
More Related Videos
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025